Suven Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Jun' 24	Mar' 24	Dec' 23	Sep' 23	Jun' 23

Sales

222.09

243.52

212.83

224.62

344.03

Operating profit

83.05

72.14

68.14

97.35

169.88

Interest

1.60

2.29

1.27

0.50

1.15

Gross profit

99.40

86.72

80.84

111.05

178.79

EPS (Rs)

2.56

2.10

2.06

2.94

4.88

Other income

17.95

16.87

13.97

14.20

10.06

Stock adjustment

21.97

17.02

6.39

8.97

21.50

Raw material

34.73

63.16

60.65

46.95

77.62

Power and fuel

-

-

-

-

-

Employee expenses

43.17

37.10

30.62

26.51

26.27

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

39.17

54.10

47.03

44.83

48.75

Provisions made

-

-

-

-

-

Depreciation

12.00

15.66

11.33

10.48

11.15

Taxation

22.32

17.62

17.14

25.84

43.35

Net profit / loss

65.08

53.43

52.36

74.73

124.29

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

25.46

25.46

25.46

25.46

25.46

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

37.39

29.62

32.01

43.34

49.38

GPM (%)

41.41

33.30

35.64

46.50

50.49

NPM (%)

27.11

20.52

23.09

31.29

35.10